About this trial
Patients with a pouch frequently suffer from chronic inflammation of the intestinal tract, called pouchitis. Pouchitis is routienly treated with repeated courses of antibiotics and probiotics, which does not stop the inflammation from recurring and exposes the patients to the risk of developing antibiotic -resistant pouchitis. Experimental data suggest that the effectiveness of the antibiotic and probiotic treatment can be prolonged by high consumption of trypotophan, an aminoacid present in everyday food. The Try Pro Pouch study aims to compare the consumption of high amounts of tryptophan against placebo in patients with pouchitis.
Eligibility criteria
Qualifiers
Pouchitis (PDAI >= 7)
indication for the application of antibiotics and probiotics
Age >=18 years
Informed consent
Disqualifiers
major surgery planned druing the intervention
high risk for malnutrition (NRS 2002 >=3/ BMI <18,5 kg/m²)
Trial design
Treatments tested in this trial
- Tryptophan 25mg/kg bodyweight
- Placebo